ARCHIVES

NIH Panel Urges Wider Treatment of Hepatitis C

This article is from The Cancer Letter archive.

Vol. 28 No. 24 | June 14, 2002

Download PDF Visit The Full Archive

Related Articles

Emory Stops Patient Accrual After Discovering Problems In Management

June 26, 2009

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

August 9, 1991

HIPAA Interpretations Vary, Delay Research, ASCO Study Finds

July 31, 2009

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010